4.5 Article

Mesenchymal Stromal Cells Do Not Increase the Risk of Viral Reactivation Nor the Severity of Viral Events in Recipients of Allogeneic Stem Cell Transplantation

Related references

Note: Only part of the references are listed.
Article Hematology

Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy

Lena von Bahr et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)

Article Hematology

Molecular monitoring of viral infections after hematopoietic stem cell transplantation

Per Ljungman

INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)

Review Hematology

Hnmunomodulatory properties of mesenchymal stromal cells

Alma J. Nauta et al.

BLOOD (2007)

Review Oncology

Potential of mesenchymal stem cell therapy

Francesco Dazzi et al.

CURRENT OPINION IN ONCOLOGY (2007)

Article Cell & Tissue Engineering

Interactions between human mesenchymal stem cells and natural killer cells

PA Sotiropoulou et al.

STEM CELLS (2006)